MedTrace Logo

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

NCT04583852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-05-24

No results posted yet for this study

Summary

This is a single center, randomized, double-blind and placebo controlled clinical study to evaluate the efficacy and safety of brightening microneedle patch on facial solar lentigines. Subjects who are 30 to 65-year-old with solar lentigines on their faces will receive brightening microneedle patches on facial solar lentigines once a day for 4 weeks. Afterwards, facial images and skin detectors will be used to analysis their skin, according to various skin tone indexes and skin response score sheets.

Conditions

  • Solar Lentigines

Interventions

OTHER

AIVÍA, Ultra-Brightening Spot Micro-needle Patch

a dissolving micro-needle patch, contains active ingredients

OTHER

Placebo Micro-needle Patch

matching placebo will be provided as a dissolving micro-needle patch

Sponsors & Collaborators

  • Panion & BF Biotech Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2021-01-08
Completion
2021-01-25

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04583852 on ClinicalTrials.gov